hotspot -WSS

hotspot

author：fashion 2025-08-23 05:22:49 - browse：69412

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

WSS

Humans aren't the only ones with an imagination. Rats have it too

How the political right came to back psychedelics to treat trauma

Brain injuries and the importance of a second opinion

Medicare proceeds with plan to claw back hospital funds

How the political right came to back psychedelics to treat trauma

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

hotspot

hotspot

entertainment

Bright Health sells Medicare Advantage business to Molina

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Malaria cases in Florida and Texas: Here’s what you need to know

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Guidelines to prevent youth baseball injuries need more muscle

Gene therapy’s promise and the high cost of hope

The cancer drug shortage isn’t new — and neither are the solutions

Prime Medicine says its gene editing passes test in monkeys

In Memoriam: Notable people who died in 2023

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

knowledge

Humans aren't the only ones with an imagination. Rats have it too

Live blog: Hearing on CRISPR

Lecanemab for Alzheimer's is coming. Is the health system ready?

DeepMind touts AlphaFold's new skills as protein folding AI models face off

How neuroscience research could help beat back brain cancer

Brain injuries and the importance of a second opinion

explore

leisure time

hotspot

hotspot